Table 1.
Total N=100 | FM N=50 | Non FM N=50 | |
---|---|---|---|
Age, years | |||
Mean (SD) | 45.1 (13.9) | 44.9 (13.9) | 45.2 (14.0) |
Range | 18–73 | 20–70 | 18–73 |
Female, N (%) | 88 (88%) | 44 (88%) | 44 (88%) |
Education | |||
Years, mean (SD) | 15.7 (2.0) | 15.7 (2.0) | 15.8 (2.0) |
Employment Status* | |||
Full-time | 19 (38) | 21 (42) | |
Part-time | 10 (20) | 17 (34) | |
Student | 4 (8) | 5 (10) | |
Unemployed | 20 (40) | 11 (22) | |
Race | |||
White | 81 (81%) | 43 (86%) | 38 (76%) |
Black | 13 (13%) | 5 (10%) | 8 (16%) |
Bi/multi-racial | 3 (3%) | 2 (4%) | 1 (2%) |
Asian | 3 (3%) | 0 (0%) | 3 (6%) |
Medication Categories, N (%) | |||
Opioid | 16 (32%) | 1 (2%) | |
SSRI | 21 (42%) | 9 (18%) | |
Tricyclic antidepressant | 5 (10%) | 0 (0%) | |
Pregabalin/gabapentin | 8 (16%) | 2 (4%) | |
Benzodiazepine | 9 (18%) | 2 (4%) | |
Sleep Aid | 13 (26%) | 0 (0%) | |
Symptoms (mean, SD) | |||
PROMIS pain intensity T- score | 45.0 (11.4) | 54.3 (6.1) | 35.6 (6.8) |
PROMIS fatigue experience T-score | 55.0 (13.8) | 65.9 (7.0) | 44.1 (9.5) |
Patient Health Questionnaire-8 (total score) | 6.2 (5.9) | 10.6 (5.2) | 1.8 (2.1) |
Note. Percentages may total to >100 because participants could select more than one category. SSRI= Selective serotonin reuptake inhibitors